Table of Contents
What changed
Revenue rose 11.4% to NZ$4.8m, and the reported loss narrowed 60.4% to NZ$0.7m (from NZ$1.7m in HY23). Because income tax expense was nil in both periods, PBT and NPAT are identical and the improvement reads cleanly through the P&L. Operating cash inflow, however, effectively disappeared: NZ$0.006m versus NZ$0.351m prior, a 98.3% decline. Cash on the balance sheet fell from NZ$8.8m to NZ$3.9m, a NZ$4.9m reduction. Gross borrowings were extinguished (NZ$0m vs NZ$0.010m), so the group remains net-cash but with materially less buffer. Trade debtors almost doubled to NZ$1.0m against a NZ$0.5m revenue lift, and total equity slipped NZ$0.3m to NZ$10.2m.
What matters
- P&L improvement is real but modest in dollar terms. The NZ$1.0m swing in pre-tax loss on a NZ$0.5m revenue uplift implies meaningful cost leverage, and ROE improved from -15.9% to -6.5%. The company remains loss-making.
- Cash conversion deteriorated sharply. Operating cash dropped to near zero even as the loss halved. The 16-day extension in receivable days (from 21.6 to 37.9) explains much of the gap — revenue growth was largely funded by receivables rather than collected in period.
- Balance-sheet runway has thinned. Cash fell NZ$4.9m year-on-year. At the current modest burn rate that is not immediately destabilising, but the cushion behind the stated strategy of reaching sustained profitability through B2B partnerships is smaller than it was twelve months ago.
Expectations
No quantified guidance, forward-work backlog, or formal target was disclosed. Management narrative flagged royalty revenue growth "in line with expectations" and neutral cash flow. Seasonality context is unhelpful here: HY23 represented only 41.9% of FY23 revenue, implying FY23 was materially second-half weighted. Annualising HY24 revenue gives NZ$9.6m, still about NZ$0.7m (6.7%) below the FY23 anchor of NZ$10.2m, so the current run rate does not yet match last year's full-year print and needs a similar H2 skew to get there. On NPAT, HY23 losses (NZ$1.7m) exceeded the full-year FY23 loss (NZ$1.4m), implying an H2 FY23 profit of NZ$0.3m — a pattern the current trajectory would need to repeat or better to narrow the full-year loss meaningfully.
Quality of result
The earnings improvement is cleanly reported (no tax distortion, no disclosed one-offs, no discontinued operation) which is a positive on transparency. Against that, the cash quality is poor. Operating cash conversion relative to the reported loss has weakened: the NZ$1.0m P&L improvement did not translate into any cash retention, and the receivables build absorbed it. Inventory days were broadly stable (31.0 vs 32.4), so the working-capital deterioration is concentrated in debtors. Without disclosed capex, payables, or an EBITDA figure, a clean free-cash-flow bridge cannot be drawn, but the direction is unambiguous: the P&L improved, the cash account did not.
Unresolved
- What drove the doubling of trade debtors — customer mix shift, timing at period end, or slower collections on B2B royalty arrangements?
- How much of the NZ$4.9m year-on-year cash decline reflects operating activities versus investing outflows (e.g. short-term deposit movements referenced in the cash flow statement)?
- With no quantified EBITDA disclosure despite EBITDA being referenced in release commentary, what is the underlying operating cash-generation capacity at the current revenue level?
- Is there a path to the H2-weighting that FY23 exhibited, or was that pattern specific to prior contract timing?
This briefing cannot assess segment economics, customer concentration, or the durability of royalty revenue streams because none of those were quantified in the supplied materials.
Key metrics
| Metric | HY24 | HY23 | Change |
|---|---|---|---|
| Revenue | $4.8m | $4.3m | +11.4% ↑ |
| Net profit after tax | −$0.7m | −$1.7m | +60.3% ↑ |
| Net cash inflow from operating activities | $0.0m | $0.4m | -98.3% ↓ |
| Declared dividend per share | — | 0.0c | — |
| Profit before tax | −$0.7m | −$1.7m | +60.3% ↑ |
| Cash and cash equivalents | $3.9m | $8.8m | -55.4% ↓ |
| Total assets | $12.0m | $12.4m | -3.9% ↓ |
Reference: annolyse.ai/briefings/blt-hy24
Analytical metrics
| Metric | HY24 | HY23 | Context |
|---|---|---|---|
| Debtor days | 37.9 | 21.6 | +16.4 days |
| Inventory days | 31.0 | 32.4 | -1.4 days |
| Trade debtors | $1.0m | $0.5m | +$0.5m |
| Net debt | −$3.9m | −$8.7m | +$4.8m |
| Gross borrowings | $0.0m | $0.0m | −$0.0m |
| Payout ratio vs NPAT | 0.0% | — | — |
| ROE (annualised) | -6.5% | -15.8% | Strengthening |
| HY23 share of FY23 revenue | 41.9% | — | Other half was 58.1% |
| HY23 share of FY23 NPAT | 125.1% | — | Other half was -25.1% |
| Profit from continuing operations | −$0.7m | −$1.7m | +$1.0m |
Reference: annolyse.ai/briefings/blt-hy24
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX/ASX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.